Editor’s Note November 15, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
Uncategorized
Editor’s Note November 8, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
Editor’s Note October 25, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
Neovasc Aims For CE Mark in 2012
OneMedRadio interviewed Alexei Marko, CEO and Director of Neovasc [CVE:NVC] where he discussed the company’s products for treating heart disease. The company’s flagship product The Reducer is in late stage development.
Editor’s Note October 17, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Editor’s Note October 3, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as well as innovative approaches to […]
Editor’s Note September 19, 2011
OneMedSentinel is pleased to bring you another round of stories and interviews with some of the most promising companies and technologies, as well as innovative […]
Editor’s Note September 12, 2011
The weather is cooling, but the health industry is heatings things up. OneMedSentinel is pleased to bring you another round of stories and interviews with […]